Sarepta drug protects lab monkeys from Ebola

February 10, 2015 2:31 PM

2 0

NEW YORK (Reuters) - An experimental Ebola drug from Sarepta Therapeutics Inc protected 75 percent of lab monkeys injected with the virus, scientists from the company and the U.S. Army reported on Tuesday.

The drug, called AVI-7537, joins ZMapp from Mapp Biopharmaceutical and a compound from Tekmira Pharmaceuticals Corp as the agents shown to cure non-human primates given otherwise-lethal injections of Ebola virus.

Read more

To category page